CELU

Celularity Inc

1.380

+0.060+4.55%

After Hours: 1.400 +0.020 +1.45%19:30 09/25 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.530/1.580

TODAY RANGE1.470-1.570

VOL68.94K

MARKET CAP47.70M

52 WEEK RANGE0.5601-2.550

AVG VOL (3M)3.89M

% TURNOVER0.21%

TURNOVER--

P/E (TTM)-0.5377

% RANGE6.33%

EPS(TTM)-2.7337

P/E(FORWARD)-0.3500

P/B-1.2165

BVPS-1.2084

DIVIDEND--

P/S1.597

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP31.84M

SHARES OUTSTANDING32.45M

NEXT EARNINGS10/21-10/24

FREE FLOAT21.66M

LOT SIZE1

EX-DATE02/29/2024

News

Press Releases

Financial Reports

Profile

TipRanks·09/29 21:49
Celularity adds Naveen Jain amid strategic recapitalization
Dow Jones·09/29 12:31
Press Release: Celularity Announces Naveen Jain to Join Board of Directors
TipRanks·09/28 10:30
Celularity Secures New Convertible Note Financing and Board Shift
NASDAQ·09/24 15:20
Celularity Closes Over $10 Mln Initial Financing; Targets Positive Operating Cash Flow By Q1 2027
Dow Jones·09/24 13:15
Press Release: Celularity Announces Over $10 -2-
Dow Jones·09/24 13:15
Press Release: Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
TipRanks·09/14 13:29
Celularity Restores Nasdaq Compliance on Key Listing Standards
NASDAQ·08/28 14:42
Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal
TipRanks·08/27 16:34
Why Is Penny Stock Celularity (CELU) Up 115% Today?
NASDAQ·08/27 14:33
Celularity Expands Cellular Medicine Manufacturing With MuseCell Innovations Partnership; Stock
TipRanks·08/27 13:05
Celularity, MuseCell Innovations announce U.S. manufacturing collaboration
Seeking Alpha·08/26 07:07
Celularity receives Nasdaq non-compliance notice over delayed 10-Q filings
NASDAQ·08/26 00:59
Celularity Faces Nasdaq Compliance Issue Over Delayed 10-Q Filings
TipRanks·08/14 22:25
Celularity Delays Quarterly SEC Filing
TipRanks·08/07 21:29
Celularity Announces Sudden Exit of Chief Commercial Officer

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.31%

866.64

Biogen Inc

BIIB

-1.62%

215.50

Amgen Inc

AMGN

+1.55%

385.65

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

0.00%

2.030

Johnson & Johnson

JNJ

-0.09%

269.99

Abbvie Inc

ABBV

+0.35%

266.69

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-2.10%

27.53

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.